Medical Xpress July 11, 2024
Medical University of Vienna

The artificial intelligence (AI) model GPT-4, known from its application in ChatGPT, shows impressive capabilities in biomedical research and can be used in many ways for simulations. A simulator developed at MedUni Vienna and based on GPT-4 shows increased accuracy in classifying the importance of genes in cancer cells, as well as in the prognosis of cancer patients.

The results of the study were published in the journal Computers in Biology and Medicine.

Large language models such as GPT-4 have proven to be extremely useful in various fields, including biomedicine. A research team from MedUni Vienna’s Institute of Artificial Intelligence and the CeMM Research Center for Molecular Medicine, led by Matthias Samwald and Christoph Bock, has shown that a large...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma, Pharma / Biotech, Survey / Study, Technology, Trends
77% of COOs Using GenAI Report Positive ROI, With Customized Tools Leading the Way
Anthropic's Claude: The AI Junior Employee Transforming Business
AI Teaches Surgery; AI Quality Registry; AI Matches Patients With Trials
Alibaba releases Qwen with Questions, an open reasoning model that beats o1-preview
Trump’s New AI Czar: Game-Changer Or A Pandora’s Box?

Share This Article